Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease

Brain

Volumn 125, Issue 10, 2002, Pages 2332-2341

  Dixon, Ruth M ^a   Bradley, Kevin M ^a   Budge, Marc M ^a   Styles, Peter ^a   Smith, A David ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Dementia; Medial temporal lobe; Neurodegeneration; Proton MRS

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; HIPPOCAMPUS; HUMAN; MALE; METABOLITE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SCORING SYSTEM; SIGNAL NOISE RATIO;

EID: 0036787479     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf226     Document Type: Article

References (31)

1. Adalsteinsson E, Sullivan EV, Kleinhans N, Spielman DM, Pfefferbaum A. Longitudinal decline of the neuronal marker Nacetyl aspartate in Alzheimer's disease. Lancet 2000; 355: 1696-7.
2. Bhakoo KK, Pearce D. In vitro expression of N-acetylaspartate by oligodendrocytes; implications for proton-magnetic resonance spectroscopy signal in vivo. J Neurochem 2000; 74: 254-62.
3. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997; 18: 351-7.
4. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. [Review]. Eur Neurol 1993; 33: 403-8.
5. Choi GC, Frahm J. Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn Reson Med 1999; 41: 204-7.
6. de Toledo Morrell L, Dickerson B, Sullivan MP, Spanovic C, Wilson R, Bennett DA. Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. Hippocampus 2000; 10: 136-42.
7. Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, et al. The biochemical pathway of neurofibrilliary degeneration in aging and Alzheimer's disease. Neurology 1999; 52: 1158-65.
8. Duvemoy HM. The human hippocampus. 2nd edn. Berlin: Springer; 1998.
9. Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J Magn Reson Ser B 1993; 102: 1-8.
10. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
11. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632-7.
12. 1H MRS study. Neurology 2001; 57: 626-32.
13. Jack CR Jr, Twomey CK, Zinsmeister AR, Sharbrough FW, Petersen RC, Cascino GD. Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology 1989; 172: 549-54.
14. Jack CR Jr, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992; 42: 183-8.
15. Jack CR Jr, Petersen RC, Xu YC, Waring SC, O'Brien PC, Tangalos EG, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997; 49: 786-94.
16. Jessen F, Block W, Traber F, Keller E, Flacke S, Papassotiropoulos A, et al. Proton MR spectroscopy detects a relative decrease of Nacetylaspartate in the medial temporal lobe of patients with AD. Neurology 2000; 55: 684-8.
17. Jessen F, Block W, Träber F, Keller E, Flacke S, Lamerichs R, et al. Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology 2001; 57: 930-2.
18. 1H MRS study. Neurology 2000; 55: 210-7.
19. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson Sers B 1993; 102: 9-19.
20. Leuba G, Kraftsik R. Visual cortex in Alzheimer's disease: occurrence of neuronal death and glial proliferation, and correlation with pathological hallmarks. Neurobiol Aging 1994; 15: 29-43.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
22. Moffett JR, Namboodiri MA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991; 2: 131-4.
23. Nagy Zs, Hindley NJ, Braak H, Braak E, Yilmazer-Hanke DM, Schultz C, et al. The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships. Dement Geriatr Cogn Disord 1999; 10: 115-20.
24. Roth M, Huppert FA, Tym E, Mountjoy CO. CAMDEX: the Cambridge examination for mental disorders of the elderly. Cambridge: Cambridge University Press; 1988.
25. Schuff N, Amend D, Ezekiel F, Steinmann SK, Tanabe J, Norman D, et al. Changes of hippocampal N-acetylaspartate and volume in Alzheimer's disease: a proton MR spectroscopic imaging and MRI study. Neurology 1997; 49: 1513-21.
26. Scott SA, DeKosky ST, Sparks DL, Knox CA, Scheff SW. Amygdala cell loss and atrophy in Alzheimer's disease. Ann Neurol 1992; 32: 555-63.
27. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991; 45: 37-45.
28. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13: 981-9.
29. Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. [Review]. Neurology 2001; 56: 592-8.
30. Watson C, Andermann F, Gloor P, Jones-Gotman M, Peters T, Evans A, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992; 42: 1743-50.
31. Wolf H, Grunwald M, Kruggel F, Riedel-Heller SG, Angerhöfer S, Hojjatoleslami A, et al. Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly. Neurobiol Aging 2001; 22: 177-86.